Clinical Use of Long-Term GnRH Agonist in Prepubertal Bitches: Effect on P4, E2 and Melatonin Serum Concentration before and During First Estrus

1 Moxon R, Freeman S, Payne R, Corr S, England GC: A prospective cohort study investigating the behavioral development of bitches in a guide dog training programme neutered prepubertally or post-pubertally. Front Vet Sci 2022, 9: 879. Search in Google Scholar

2 Moxon R, Freeman SL, Payne R, Corr S, England GC: A prospective cohort study investigating the peri-and postoperative outcomes following ovariohysterectomy in bitches neutered prepubertally or post-pubertally. Theriogenology 2023, 197, 283–294. Search in Google Scholar

3 Lucas X: Clinical use of deslorelin (GnRH agonist) in companion animals: a review. Reprod in Dom Anim 2014, 49, 64–71. Search in Google Scholar

4 Romagnoli S: Early-age neutering in dogs and cats: advantages and disadvantages. Rev Bras Reprod Anim 2017, 41, 1:130–132. Search in Google Scholar

5 Salavati S, Mogheiseh A, Nazifi S, Tabrizi AS, Taheri P, Koohi F: Changes in sexual hormones, serotonin, and cortisol concentrations following oral administration of melatonin in castrated and intact dogs. J Vet Behav 2018, 27, 27–34. Search in Google Scholar

6 Yates D, Leedham R: Prepubertal neutering of dogs—some risks and benefits. Companion Animal 2019, 24: 38–42. Search in Google Scholar

7 Schäfer-Somi S, Kaya D, Aslan S: Prepubertal Use of Long-Term GnRH Agonists in Dogs: Current Knowledge and Recommendations. Animals 2022, 12,17, 2267. Search in Google Scholar

8 Kutzler M, Wood A: Non-surgical methods of contraception and sterilization. Theriogenology 2006, 66,3: 514–525. Search in Google Scholar

9 Rhodes L: New approaches to non-surgical sterilization for dogs and cats: Opportunities and challenges. Reprod Domest Anim 2017, 52, 327–331. Search in Google Scholar

10 Asa CS: Contraception in dogs and cats. Vet Clin N Am 2018, 48, 4: 733–742. Search in Google Scholar

11 Borges P, Fontaine E, Maenhoudt C, Payan-Carreira R, Santos N, Leblond E, Fontaine C, Fontbonne A: Fertility in adult bitches previously treated with a 4.7 mg subcutaneous deslorelin implant. Reprod in Dom Anim, 2015, 50, 6, 965–71. Search in Google Scholar

12 Romagnoli S, Nassuato C, Stelletta C, Mollo A, Gelli D: Serum Testosterone Concentrations on Scrotal Diameter in Male Dogs Treated With Deslorelin Implants. In: Proceeding Congress European Veterinary Society for Small Animal Reproduction Amsterdam 2005, The Netherlands, 14th April, pp. 27–28. Search in Google Scholar

13 Romagnoli S, Siminica A, Sontas BH, Milani C, Stelleta C: Semen quality and onset of sterility following administration of a 4.7-mg Deslorelin implant in adult male dogs. Reprod Domest Anim 2012, 47, 6: 389–392. Search in Google Scholar

14 Fontaine E and Fontbonne A: Clinical use of GnRH agonists in canine and feline species. Reprod Domest Anim, 2011, 46, 344–353. Search in Google Scholar

15 Driancourt MA, Briggs JR: Gonadotropin-releasing hormone (GnRH) agonist implants for male dog fertility suppression: a review of mode of action, efficacy, safety, and uses. Front Vet Sci 2020, 7, 483. Search in Google Scholar

16 Volkmann DH, Kutzler MA, Wheeler R, Krekeler N: The use of deslorelin implants for the synchronization of estrous in diestrous bitches. Theriogenology 2006, 66, 1497–1501. Search in Google Scholar

17 Kutzler M, Lamb SV, Volkmann D: Comparison between vestibular and subcutaneous insertion of deslorelin implants for oestrus induction in bitches. Reprod Domest Anim 2009 44, 2: 83–86. Search in Google Scholar

18 Fontaine E, Mir F, Vannier F, Gerardin A, Albouy M, Navarro C, Fontbonne A: Induction of fertile oestrus in the bitch using Deslorelin, a GnRH agonist. Theriogenology 2011, 76, 1561–1566. Search in Google Scholar

19 Fontaine E, Fontbonne A: Use of deslorelin to control fertility in the bitch. In 7th European Veterinary Society Small Animal Reproduction (EVSSAR) Congress 2010, Louvain-la-Neuve, Belgium, May 15–15, pp. 9–10. Search in Google Scholar

20 Haldar C: Experimental endocrinology and reproductive biology. Science Publishers 2007. Search in Google Scholar

21 Paramo RM, Renton JP, Ferguson JM, Concannon PW: Effects of medroxyprogesterone acetate or gonadotrophin releasing hormone agonist on suppression of spermatogenesis in the dog (Canis familiaris). J Reprod Fertil 1993, 47, 387–397 Search in Google Scholar

22 Trigg TE, Wright PJ, Armour AF, Williamson PE, Junaidi A, Martin GB, Doyle AG, Walsh J: Use of GnRH analogue implant to produce reversible long-term suppression of reproductive function of male and female domestic dogs. J Reprod Fert Suppl 2001, 57, 255–261. Search in Google Scholar

23 Junaidi A, Williamson PE, Martin GB, Blackberry MA, Cummins JM, Trigg TE: Dose– response studies for pituitary and testicular function in male dogs treated with the GnRH superagonist, deslorelin. Reprod Domest Anim 2009, 44, 5: 725–734. Search in Google Scholar

24 Junaidi A, Williamson PE, Martin GB, Stanton PG, Blackberry MA, Cummins JM, Trigg TE: Pituitary and testicular endocrine responses to exogenous GnRH and LH in male dogs treated with GnRH agonist implants. Reprod Fert Dev 2007, 19, 891–898. Search in Google Scholar

25 Junaidi A, Williamson PE, Trigg TE, Cummins JM, Martin GB: Morphological study of the effects of the GnRH super agonist deslorelin on the canine testis and prostate gland. Reprod Dom Anim 2009, 44, 5: 757–763. Search in Google Scholar

26 Johnston SD, Kustritz MV, Olson PN: Canine and Feline Theriogenology, 1st ed.; Philadelphia, USA: Saunders; 2001. Search in Google Scholar

27 Gobello C: Prepubertal and pubertal canine reproductive studies: Conflicting aspects. Reprod Domest Anim 2014, 49, 70–73. Search in Google Scholar

28 Rubion S, Desmoulins PO, Rivière-Godet E, Kinziger M, Salavert F, Rutten F, A. Flochlay-Sigognault, Driancourt MA: Treatment with a subcutaneous GnRH agonist containing controlled release device reversibly prevents puberty in bitches. Theriogenology 2006, 66, 1651–4. Search in Google Scholar

29 Trigg TE, Doyle AG, Walsh JD, Swangchanuthai T: A review of advances in the use of the GnRH agonist deslorelin in control of reproduction. Theriogenology 2006, 66, 1507–12. Search in Google Scholar

30 Kaya D, Aslan S, Kaya S, Kuru M, Kacar C, Schäfer-Somi S: Clinical and endocrine short-term effects of GnRH analogue deslorelin in prepubertal bitches: does a “flare-up” occur? Kafkas Univ Vet Fak Derg 2013, 19, 2, 299–304. Search in Google Scholar

31 Kaya D, Schäfer-Somi, Kurt B, Kuru M, Kaya S, Kaçar C, Aksoy Ö, Aslan S: Clinical use of deslorelin implants for the long-term contraception in prepubertal bitches: Effects on epiphyseal closure, body development, and time to puberty. Theriogenology 2015, 83,7, 1147–1153. Search in Google Scholar

32 Faya M, Marchetti C, Priotto M, Grisolía M, D’Francisco F, Gobello C: Postponement of canine puberty by neonatal administration of a long-term release GnRH super agonist. Theriogenology 2018, 118, 190–195. Search in Google Scholar

33 Schäfer-Somi S, Kaya D, Sözmen M, Kaya S, Aslan S: Pre-pubertal treatment with a GnRH agonist in bitches-Effect on the uterus and hormone receptor expression. Reprod in Dom Anim 2018, 53, 103–109. Search in Google Scholar

34 Kaya D, Gram A, Kowalewski MP, Schäfer-Somi S, Kuru M, Boos A, Aslan S: Expression of GnRH receptor in the canine corpus luteum, and luteal function following deslorelin acetate-induced puberty delay. Reprod Domest Anim 2017, 52,6: 1104–12. Search in Google Scholar

35 Lakin ML, Miller CH, Stott ML, Winters WD: Involvement of the pineal gland and melatonin in murine analgesia. Life Sci 1981, 29: 2543–2551. Search in Google Scholar

36 Sugden D: Psychopharmacological effects of melatonin in mouse and rat. J Pharm Exp Ther 1983, 227: 587–591. Search in Google Scholar

37 Yu C, Weng S, Chen C: Studies on the analgesic effect and physical dependence of melatonin in mice. Chin J Drug Depend 1999, 8: 58–60. Search in Google Scholar